Particle.news
Patient Outcomes GLP-1 Agonists Polypill Studies Omalizumab Drug Trials Omalizumab (Xolair) Trials Phase II Studies Antibiotic Efficacy Mouse Models Laboratory Studies Adverse Effects
Selective serotonin reuptake inhibitors (SSRIs) shrink tumors and enhance T cell activity in preclinical cancer models, paving the way for clinical trials.
